First UK real-world study shows promise for sacituzumab govitecan in metastatic breas
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
More... |
All times are GMT -7. The time now is 07:04 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021